article thumbnail

How do Healthcare AI Developers (and Buyers) Stay Ahead of the Regulatory Curve?

Nixon Gwilt Law

That said, the flurry of regulatory policymaking and legislation, congressional hearings and inquiries, and industry stakeholder organization around the development and deployment of healthcare AI portends major developments in the coming years. HIPAA is the pantheon of healthcare data privacy regulation in the U.S. HIPAA What is it?

article thumbnail

Women’s Health Marketing: How to Reach Women Healthcare Consumers

Healthcare Success

When it comes to the household, they make up to 90 percen t of the healthcare decisions. Ninety four percent of women make their own healthcare decisions, and 59 percent of women make healthcare decisions for others. How do we better market to women healthcare consumers? What a blow to our industry and to our women.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Canadian and US developers to trial psychedelic medicines in UK

European Pharmaceutical Review

The UK’s regulatory pathway and fast-track drug approval process enables companies to fast-track their ethics applications and combine their reviews. The regulators are the Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA) respectively.

Medicine 100
article thumbnail

Why Is FDA Issuing Fewer Marketing Violation Letters?

Pharma Marketing Network

The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled. The post Why Is FDA Issuing Fewer Marketing Violation Letters? appeared first on Pharma Marketing Network.

article thumbnail

2022 Trends and Opportunities for Healthcare and Life Sciences Businesses and Investors

Nixon Gwilt Law

What can Healthcare and Life Sciences businesses and investors anticipate for the healthcare industry in 2022? We asked our team five direct questions about innovations in healthcare, life sciences, and digital health in the coming year: What healthcare trends or opportunities are you most excited about?

article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

Regulatory bodies such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) place great importance on data integrity in the pharmaceutical/life science industry. Ethical leadership is essential in promoting a culture of integrity within an organisation.

article thumbnail

Life sciences faces a battle with sustainability, but let’s not forget its successes

pharmaphorum

We know that the global healthcare sector is a contributor to the warming of our planet. Rises in respiratory illness from air pollution and allergens, food and water-borne illness, physical injury from extreme weather events and mental health threats are just some of the climate-sensitive consequences that characterise the unfolding crisis.